About Sumatriptan Succinate API
Therapeutic CategoryPain Management
CAS Number
103628-48-4
API Technology
Synthetic
Dose Form
Injectable
Dr Reddy's Development Status
Available
Available Regulatory Filing
USDMF, CEP Submitted, Brazil DMF, EUDMF, Japan DMF, Russia DMF
Mechanism of Action
Sumatriptan binds with high affinity to human cloned 5-HT1B/1D receptors. Sumatriptan presumably exerts its therapeutic effects in the treatment of migraine headache through agonist effects at the 5-HT1B/1D receptors on intracranial blood vessels and sensory nerves of the trigeminal system, which result in cranial vessel constriction and inhibition of pro-inflammatory neuropeptide release.
Indication
ZEMBRACE SymTouch is a serotonin (5-HT1B/1D) receptor agonist (triptan) indicated for:
- Acute treatment of migraine with or without aura in adults Limitations of Use:
- Use only if a clear diagnosis of migraine has been established.
- Not indicated for the prophylactic therapy of migraine.
Related APIs
萘普生
Pain Management
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!